4.6 Article

The dengue virus envelope protein induced PAI-1 gene expression via MEK/ERK pathways

Journal

THROMBOSIS AND HAEMOSTASIS
Volume 104, Issue 6, Pages 1219-1227

Publisher

GEORG THIEME VERLAG KG
DOI: 10.1160/TH10-05-0302

Keywords

Flaviviridae; dengue virus type 2; envelope glycoprotein domain III; plasminogen activator inhibitor type-1

Funding

  1. National Science Council [NSC-98-2320-B-242-001-MY3]

Ask authors/readers for more resources

Dengue virus (DV) infections cause mild dengue fever or severe life-threatening dengue haemorrhagic fever (DHF)/ dengue shock syndrome (DSS). DV-infected patients have high plasma concentrations of plasminogen activator inhibitor type 1 (PAI-1). However, the mechanism to cause haemorrhage in DV infections remains poorly understood. In this study, investigation was carried out on the purified recombinant domain III of the envelope glycoprotein of DV serotypes 2 (EIII) and the signalling pathways of EIII leading to PAI-1 gene expression were measured by RT-PCR, Western blot, and immunofluorescence stain. Reporter gene constructs containing serially 5'-deleted sequences of the proximal human PAI-1 promoter region were constructed and then transfected to Huh7 cells, a human hepatoma cell line, prior to EIII treatment. EIII increased the PAI-1 mRNA and protein levels in a dose-dependent manner in Huh7 cells. Results showed that U0126, an inhibitor of extracellular signal-regulated kinase (ERK) kinase (MEK), almost completely suppressed EIII-induced PAI-1 expression. The results suggest that the MEK/ERK signalling pathways mediate the Ern-dependent induction of PAI-1 gene expression via the proximal promoter region.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy

Yen-Chung Lai, Yung-Chun Chuang, Chih-Peng Chang, Yee-Shin Lin, Guey-Chuen Perng, Han-Chung Wu, Shie-Liang Hsieh, Trai-Ming Yeh

ANTIVIRAL RESEARCH (2018)

Article Infectious Diseases

Inhibition of autophagy protects against sepsis by concurrently attenuating the cytokine storm and vascular leakage

Liang-Hsuan Lu, Chiao-Hsuan Chao, Trai-Ming Yeh

JOURNAL OF INFECTION (2019)

Article Microbiology

Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage

Chiao-Hsuan Chao, Wei-Chueh Wu, Yen-Chung Lai, Pei-Jane Tsai, Guey-Chuen Perng, Yee-Shin Lin, Trai-Ming Yeh

PLOS PATHOGENS (2019)

Article Immunology

Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection

Yu-San Kao, Chia-Yi Yu, Hong-Jyun Huang, Sen-Mao Tien, Wan-Yu Wang, Martyr Yang, Robert Anderson, Trai-Ming Yeh, Yee-Shin Lin, Shu-Wen Wan

JOURNAL OF IMMUNOLOGY (2019)

Article Medicine, Research & Experimental

Regulation of autophagy, glucose uptake, and glycolysis under dengue virus infection

Ying-Ray Lee, Shan-Ying Wu, Ruei-Yi Chen, Yee-Shin Lin, Trai-Ming Yeh, Hsiao-Sheng Liu

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)

Review Microbiology

Roles of Macrophage Migration Inhibitory Factor in Dengue Pathogenesis: From Pathogenic Factor to Therapeutic Target

Yen-Chung Lai, Chiao-Hsuan Chao, Trai-Ming Yeh

MICROORGANISMS (2020)

Article Biochemistry & Molecular Biology

Dengue Nonstructural Protein 1 Maintains Autophagy through Retarding Caspase-Mediated Cleavage of Beclin-1

Zi-Yi Lu, Miao-Huei Cheng, Chia-Yi Yu, Yee-Shin Lin, Trai-Ming Yeh, Chia-Ling Chen, Chien-Chin Chen, Shu-Wen Wan, Chih-Peng Chang

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Zonal-Layered Chondrocyte Sheets for Repairment of Full-Thickness Articular Cartilage Defect: A Mini-Pig Model

Po-Chih Shen, Cheng-Chang Lu, Shih-Hsiang Chou, Zi-Miao Liu, Shu-Jem Su, Yin-Chun Tien

Summary: This study compared stratified chondrocyte sheets (S-CS) and heterogeneous chondrocyte sheets (H-CS) in terms of expression and therapeutic effects, revealing that the S-CS group exhibited higher cell viability, proliferation rate, expression of chondrogenic markers, secretion of tissue inhibitor of metalloproteinase, and GAG production level. The mini-pigs articular cartilage defect model showed that the S-CS group had a higher International Cartilage Repair Society (ICRS) macroscopic score and displayed a zonal structure closer to native cartilage.

BIOMEDICINES (2021)

Article Immunology

A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein

Hong-Jyun Huang, Martyr Yang, Hsin-Wei Chen, Shuying Wang, Chih-Peng Chang, Tzong-Shiann Ho, Yu-San Kao, Sen-Mao Tien, Hsing-Han Lin, Po-Chun Chang, Yen-Chung Lai, Yu-Peng Hsiao, Yi-Ling Liu, Chiao-Hsuan Chao, Robert Anderson, Trai-Ming Yeh, Yee-Shin Lin, Shu-Wen Wan

Summary: This study developed a modified DENV vaccine candidate with enhanced features by combining modifications of two DENV proteins. The vaccine candidate showed protective effects against DENV infection in a mouse model, indicating its potential clinical application.

VACCINE (2022)

Article Microbiology

Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model

Sen-Mao Tien, Po-Chun Chang, Yen-Chung Lai, Yung-Chun Chuang, Chin-Kai Tseng, Yu-San Kao, Hong-Jyun Huang, Yu-Peng Hsiao, Yi-Ling Liu, Hsing-Han Lin, Chien-Chou Chu, Miao-Huei Cheng, Tzong-Shiann Ho, Chih-Peng Chang, Shu-Fen Ko, Che-Piao Shen, Robert Anderson, Yee-Shin Lin, Shu-Wen Wan, Trai-Ming Yeh

Summary: Dengue virus (DENV) is a global health problem without effective treatment. This study demonstrates the potential of humanized anti-NS1 monoclonal antibodies (mAbs) as a therapeutic tool for DENV infection. The humanized mAbs showed therapeutic benefits in reducing bleeding time and skin hemorrhage, and they also inhibited vascular permeability and enhanced cytolysis of DENV-infected cells.

PLOS PATHOGENS (2022)

Article Immunology

Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2

Yen-Chung Lai, Yu-Wei Cheng, Chiao-Hsuan Chao, Yu-Ying Chang, Chi-De Chen, Wei-Jiun Tsai, Shuying Wang, Yee-Shin Lin, Chih-Peng Chang, Woei-Jer Chuang, Li-Yin Chen, Ying-Ren Wang, Sui-Yuan Chang, Wenya Huang, Jen-Ren Wang, Chin-Kai Tseng, Chun-Kuang Lin, Yung-Chun Chuang, Trai-Ming Yeh

Summary: In COVID-19 patients, elevated levels of ACE2 antibodies were found to cross-react with S1-RBD antibodies, suggesting a potential mechanism of immune response induced by SARS-CoV-2 infection. This cross-reactivity highlights the complex interactions between the virus and the host immune system in COVID-19 pathogenesis.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis

Yi-Ling Cheng, Chiao-Hsuan Chao, Yen-Chung Lai, Kun-Han Hsieh, Jen-Ren Wang, Shu-Wen Wan, Hong-Jyun Huang, Yung-Chun Chuang, Woei-Jer Chuang, Trai-Ming Yeh

Summary: This study confirms the presence of antibodies related to SARS-CoV-2 in dengue virus patients, and these antibodies can cross-react with proteins of the dengue virus. These antibodies can inhibit the pathological reactions caused by dengue virus infection, potentially providing some level of protection against dengue virus.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan

Chiao-Hsuan Chao, Dayna Cheng, Sheng-Wen Huang, Yung-Chun Chuang, Trai-Ming Yeh, Jen-Ren Wang

Summary: This study collected serum samples from 113 Taiwan participants after receiving different SARS-CoV-2 vaccines and compared the differences in immune responses. The results showed that mRNA vaccines elicited higher levels of antibodies and had higher broadly neutralizing ability compared to AZD1222. Additionally, the study found a significant increase in anti-ACE2 autoantibodies after vaccination.

FRONTIERS IN IMMUNOLOGY (2022)

Meeting Abstract Immunology

Development of dengue virus vaccine by targeting at nonstructural protein 1 wing domain

T. M. Yeh

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Review Cell Biology

Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate

Hong-Ru Chen, Yen-Chung Lai, Trai-Ming Yeh

JOURNAL OF BIOMEDICAL SCIENCE (2018)

No Data Available